The Ethics of Translating High-Throughput Science into Clinical Practice
Biomedical research is increasingly data intensive and computational, and “big data science” is migrating into the clinical arena. Unfortunately, ethicists, regulators, and policy‐makers have barely begun to explore the ethical, legal, and social issues raised by the variety of analytical and comput...
Saved in:
Published in | The Hastings Center report Vol. 44; no. 5; pp. 8 - 9 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
United States
Blackwell Publishing Ltd
01.09.2014
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Biomedical research is increasingly data intensive and computational, and “big data science” is migrating into the clinical arena. Unfortunately, ethicists, regulators, and policy‐makers have barely begun to explore the ethical, legal, and social issues raised by the variety of analytical and computational approaches in use and under development in biology and medicine. Most scholarship concerning big data bioscience has focused on privacy, a vitally important consideration but not the only one. Among the issues raised by new computational technologies are questions about safety and safety assessment, justice, and how to obtain proper informed consent. These technologies also raise a myriad of regulatory issues that could influence the probability of translating new assays or computational tools to the clinical or public health spheres. |
---|---|
Bibliography: | ArticleID:HAST351 ark:/67375/WNG-XN6P83MN-7 istex:7ED97482203CA92927DD3EEF90F861EF63FA77C8 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0093-0334 1552-146X |
DOI: | 10.1002/hast.351 |